ZimVie Inc (ZIMV)
17.01
+0.03
(+0.18%)
USD |
NASDAQ |
May 17, 16:00
17.01
0.00 (0.00%)
After-Hours: 20:00
ZimVie Revenue (Quarterly): 118.20M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 118.20M |
| December 31, 2023 | -195.76M |
| September 30, 2023 | 202.87M |
| June 30, 2023 | 224.90M |
| March 31, 2023 | 120.41M |
| December 31, 2022 | -221.45M |
| September 30, 2022 | 214.58M |
| Date | Value |
|---|---|
| June 30, 2022 | 234.56M |
| March 31, 2022 | 235.60M |
| December 31, 2021 | -280.77M |
| September 30, 2021 | 239.62M |
| June 30, 2021 | 265.73M |
| March 31, 2021 | 247.73M |
| December 31, 2020 | 274.93M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-280.77M
Minimum
Dec 2021
274.93M
Maximum
Dec 2020
120.08M
Average
219.74M
Median
Revenue (Quarterly) Benchmarks
| Orthofix Medical Inc | 188.61M |
| Stryker Corp | 5.243B |
| Globus Medical Inc | 606.67M |
| Paragon 28 Inc | 61.08M |
| Perspective Therapeutics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.761M |
| Total Expenses (Quarterly) | 117.31M |
| EPS Diluted (Quarterly) | -0.29 |
| Enterprise Value | 929.99M |
| Gross Profit Margin (Quarterly) | 62.56% |
| Profit Margin (Quarterly) | -6.57% |
| Earnings Yield | -82.43% |
| Normalized Earnings Yield | -5.559 |